volkova 19 vaccine makers are still |
3.52 |
Jump to 3.6 |
|
|
leading one |
2.96 |
Jump to 39.36 |
|
|
kept kobe 19 so so really it's been |
5.44 |
Jump to 55.52 |
|
|
and one of the things that you're really |
3.44 |
Jump to 68.56 |
|
|
about second half of the year what sort |
6.72 |
Jump to 147.36 |
|
|
some quality issues in a one of our with |
4.64 |
Jump to 172.64 |
|
|
one of our contract manufacturers |
3.84 |
Jump to 175.28 |
|
|
of the first half of the year yeah so we |
6.8 |
Jump to 183.519 |
DATE
the first half of the year
|
|
can really from the second half of 2022 |
7.12 |
Jump to 185.92 |
DATE
the second half of 2022
|
|
second half of this year will be a |
2.24 |
Jump to 193.04 |
|
|
so we have one particular issue in one |
4.801 |
Jump to 216.319 |
|
|
the for the 2022 outlook and looking at |
4.56 |
Jump to 270.88 |
|
|
where there is one single buyer |
5.04 |
Jump to 385.52 |
|
|
average 75 in rebates and for instance |
5.359 |
Jump to 397.28 |
|
|
only have one price which is the net |
4.481 |
Jump to 411.199 |
|
|
launched in in the us as the first |
4.641 |
Jump to 448.479 |
|
|